WILLIAM TOMPKINS: Open Payments
NPI 1396499737 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 71 payments from 18 companies in 2025. Trend: 2023 $1,469 · 2024 $1,653 · 2025 $1,386
Food & beverage: $1,386
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $207 |
| ABBVIE INC. | 9 | $169 |
| Novo Nordisk Inc | 11 | $160 |
| Lilly USA, LLC | 11 | $159 |
| Amgen Inc. | 8 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| PFIZER INC. | 4 | $82 |
| Sumitomo Pharma America, Inc. | 4 | $67 |
| Viatris Specialty LLC | 3 | $63 |
| Exact Sciences Corporation | 3 | $62 |
Products named: BREZTRI, MOUNJARO, OTEZLA, Ozempic, GEMTESA, OFEV, YUPELRI, Cologuard Collection Kit.
Industry payments across AR — which companies pay providers there.
